Evidence map›Paper›PMID 35158849›Full record

ArticleCancers2022

Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models.

Carolyn Shembrey, Jai Smith, Mélodie Grandin, Nathalia Williams, Hyun-Jung Cho, Christina Mølck, Corina Behrenbruch, Benjamin Nj Thomson, Alexander G Heriot, Delphine Merino and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. [Research progress on vascularization of organoids].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Carolyn ShembreyDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.
Jai SmithDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.ORCID 0000-0003-4997-6189
Mélodie GrandinDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.
Nathalia WilliamsDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.ORCID 0000-0003-2279-5302
Hyun-Jung ChoBiological Optical Microscopy Platform, University of Melbourne, Melbourne, VIC 3010, Australia.ORCID 0000-0002-2932-1890
Christina MølckDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.
Corina BehrenbruchDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.
Benjamin Nj ThomsonDepartment of General Surgical Specialties, The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia.
Alexander G HeriotThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.
Delphine MerinoOlivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
Frédéric HollandeDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia.ORCID 0000-0002-7046-8392
The University of Melbourne · AUThe Royal Melbourne Hospital · AU

Funding

National Health and Medical Research Council GNT1164081Tour de Cure Foundation, Australia Senior Research Grant
6 · The paper itself

Abstract

Geno- and phenotypic heterogeneity amongst cancer cell subpopulations are established drivers of treatment resistance and tumour recurrence. However, due to the technical difficulty associated with studying such intra-tumoural heterogeneity, this phenomenon is seldom interrogated in conventional cell culture models. Here, we employ a fluorescent lineage technique termed "optical barcoding" (OBC) to perform simultaneous longitudinal tracking of spatio-temporal fate in 64 patient-derived colorectal cancer subclones. To do so, patient-derived cancer cell lines and organoids were labelled with discrete combinations of reporter constructs, stably integrated into the genome and thus passed on from the founder cell to all its clonal descendants. This strategy enables the longitudinal monitoring of individual cell lineages based upon their unique optical barcodes. By designing a novel panel of six fluorescent proteins, the maximum theoretical subpopulation resolution of 64 discriminable subpopulations was achieved, greatly improving throughput compared with previous studies. We demonstrate that all subpopulations can be purified from complex clonal mixtures via flow cytometry, permitting the downstream isolation and analysis of any lineages of interest. Moreover, we outline an optimized imaging protocol that can be used to image optical barcodes in real-time, allowing for clonal dynamics to be resolved in live cells. In contrast with the limited intra-tumour heterogeneity observed in conventional 2D cell lines, the OBC technique was successfully used to quantify dynamic clonal expansions and contractions in 3D patient-derived organoids, which were previously demonstrated to better recapitulate the heterogeneity of their parental tumour material. In summary, we present OBC as a user-friendly, inexpensive, and high-throughput technique for monitoring intra-tumoural heterogeneity in in vitro cell culture models.

Indexed as

cell culture techniquescell lineageclonal evolutioncolorectal neoplasmslongitudinal imagingmetastasisneoplasm recurrenceorganoidsself-renewaltumour heterogeneity

Identifiers

PMID35158849
PMCPMC8833441
OpenAlexW4210543561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.